Rifampicin Plus Colistin in the Era of Extensively Drug-Resistant Acinetobacter baumannii Infections

被引:4
作者
Gauthier, Timothy P. [1 ]
机构
[1] Nova SE Univ, Coll Pharm, Dept Pharm Practice, Ft Lauderdale, FL 33328 USA
关键词
Acinetobacter baumannii; colistin; rifampicin; antimicrobial resistance; CRITICALLY-ILL PATIENTS; METHANESULFONATE; MULTICENTER;
D O I
10.1093/cid/cit262
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:359 / 361
页数:3
相关论文
共 17 条
[1]   2012 and beyond: potential for the start of a second pre-antibiotic era? [J].
Appelbaum, Peter C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (09) :2062-2068
[2]   Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia [J].
Aydemir, H. ;
Akduman, D. ;
Piskin, N. ;
Comert, F. ;
Horuz, E. ;
Terzi, A. ;
Kokturk, F. ;
Ornek, T. ;
Celebi, G. .
EPIDEMIOLOGY AND INFECTION, 2013, 141 (06) :1214-1222
[3]   Update on rifampin, rifabutin, and rifapentine drug interactions [J].
Baciewicz, Anne M. ;
Chrisman, Cary R. ;
Finch, Christopher K. ;
Self, Timothy H. .
CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (01) :1-12
[4]   Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections [J].
Bassetti, M. ;
Repetto, E. ;
Righi, E. ;
Boni, S. ;
Diverio, M. ;
Molinari, M. P. ;
Mussap, M. ;
Artioli, S. ;
Ansaldi, F. ;
Durando, P. ;
Orengo, G. ;
Pallavicini, F. Bobbio ;
Viscoli, C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) :417-420
[5]   Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies [J].
Cai, Yun ;
Chai, Dong ;
Wang, Rui ;
Liang, Beibei ;
Bai, Nan .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (07) :1607-1615
[6]   Can Pharmacokinetic and Pharmacodynamic Principles Be Applied to the Treatment of Multidrug-Resistant Acinetobacter? [J].
Cooper, Travis W. ;
Pass, Steven E. ;
Brouse, Sara D. ;
Hall, Ronald G., II .
ANNALS OF PHARMACOTHERAPY, 2011, 45 (02) :229-240
[7]   High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study [J].
Dalfino, Lidia ;
Puntillo, Filomena ;
Mosca, Adriana ;
Monno, Rosa ;
Spada, Maria Luigia ;
Coppolecchia, Sara ;
Miragliotta, Giuseppe ;
Bruno, Francesco ;
Brienza, Nicola .
CLINICAL INFECTIOUS DISEASES, 2012, 54 (12) :1720-1726
[8]   Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial [J].
Durante-Mangoni, Emanuele ;
Signoriello, Giuseppe ;
Andini, Roberto ;
Mattei, Annunziata ;
De Cristoforo, Maria ;
Murino, Patrizia ;
Bassetti, Matteo ;
Malacarne, Paolo ;
Petrosillo, Nicola ;
Galdieri, Nicola ;
Mocavero, Paola ;
Corcione, Antonio ;
Viscoli, Claudio ;
Zarrilli, Raffaele ;
Gallo, Ciro ;
Utili, Riccardo .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (03) :349-358
[9]   Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients [J].
Garonzik, S. M. ;
Li, J. ;
Thamlikitkul, V. ;
Paterson, D. L. ;
Shoham, S. ;
Jacob, J. ;
Silveira, F. P. ;
Forrest, A. ;
Nation, R. L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (07) :3284-3294
[10]   The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020 [J].
Gilbert, David N. ;
Guidos, Robert J. ;
Boucher, Helen W. ;
Talbot, George H. ;
Spellberg, Brad ;
Edwards, John E., Jr. ;
Scheld, W. Michael ;
Bradley, John S. ;
Bartlett, John G. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) :1081-1083